- Home
- DRD vs SLNO Comparison
DRD vs SLNO Comparison
Compare DRD & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRD | SLNO |
|---|---|---|
| Founded | 1895 | 1999 |
| Country | South Africa | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | DRD | SLNO |
|---|---|---|
| Price | $30.47 | $50.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $27.50 | ★ $110.90 |
| AVG Volume (30 Days) | 457.3K | ★ 1.6M |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ 68.66 | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | ★ $443,674,785.00 | $98,675,000.00 |
| Revenue This Year | $18.10 | N/A |
| Revenue Next Year | $25.92 | $155.86 |
| P/E Ratio | $21.54 | ★ N/A |
| Revenue Growth | ★ 26.26 | N/A |
| 52 Week Low | $8.38 | $41.50 |
| 52 Week High | $33.31 | $90.32 |
Technical Indicators
Market Signals| Indicator | DRD | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 58.43 | 46.99 |
| Support Level | $28.04 | $48.60 |
| Resistance Level | $33.31 | $55.47 |
| Average True Range (ATR) | 1.31 | 2.75 |
| MACD | 0.15 | 0.70 |
| Stochastic Oscillator | 52.01 | 46.16 |
Price Performance
Historical ComparisonAbout DRD DRDGOLD Limited
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.